Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
Circulation. Cardiovascular Interventions|March 16, 2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor PretreatmentJeremie Abtan, Gregory Ducrocq, Philippe Gabriel Steg, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Circulation. Cardiovascular Interventions|May 12, 2026
Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval StudyChristina Lalani, Eric Secemsky, Yang Song, et al.
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
The Journal of Invasive Cardiology|May 30, 2006
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stentingMatthew J Price, Jeffrey W Moses, Martin B Leon, et al.
Structural Heart : the Journal of the Heart Team|December 1, 2025
Impact of Central vs. Noncentral Predominant Jet Location on Clinical Outcomes: Results From the EXPANDed StudiesJason H Rogers, Matthew J Price, Gagan D Singh, et al.
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JACC. Cardiovascular Interventions|October 25, 2023
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 StudyRalph Stephan von Bardeleben, Paul Mahoney, M Andrew Morse, et al.
Circulation|January 15, 2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) TrialMichelle L O'Donoghue, Deepak L Bhatt, Gregg W Stone, et al.
Circulation|August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
Pageof 28